Genentech / Evrysdi
(https://evrysdi.com) 📸 Data Snapshot: May 30, 2026Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Authority is well-established through Genentech’s corporate identity and the drug’s FDA-approved status. While the site features patient ambassadors like ‘Jose,’ it relies more on institutional authority and regulatory compliance than named individual ‘gurus,’ which is consistent with high-substance biotech models. The schema_json includes detailed Organization and MedicalWebPage data, leaving no significant identity gaps.
There is no significant disconnect between claims and evidence. Performance claims regarding motor function preservation are clearly footnoted with the caveat ‘This was observed when Evrysdi was studied in animals’ where applicable, and clinical results are supported by line graphs and data exploration links rather than vague marketing assertions.
Identity & Authority is read from the structured data first: whether the site declares who it is in machine-readable schema, with verifiable identity links. Below is the schema captured per page, then the external proof links that support (or fail to support) that identity.
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps
Homepage schema
[
{
"@context": "http://schema.org",
"@type": "Organization",
"name": "Genentech",
"url": "https://www.gene.com/",
"logo": "https://www.gene.com/assets/frontend/img/Genentech_logo.png",
"description": "Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.",
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+1-877-436-3683",
"contactType": "customer service"
},
"address": {
"@type": "PostalAddress",
"streetAddress": "1 DNA Way",
"addressLocality": "South San Francisco",
"addressRegion": "California",
"postalCode": "94080",
"addressCountry": "US"
}
},
{
"@context": "schema.org",
"@type": "MedicalWebPage",
"url": "https://www.evrysdi.com/",
"description": "Evrysdi® (risdiplam) is a Spinal Muscular Atrophy (SMA) treatment that can be administered at home and is approved for use in adults, children, and infants. Please see Important Safety information, including the Full Prescribing Information for more details.",
"MedicalAudience": "https://schema.org/Patient",
"about": [
{
"@type": "Drug",
"name": "Evrysdi®",
"nonProprietaryName": "risdiplam",
"dosageForm": [
"Liquid",
"Tablet"
],
"administrationRoute": [
"Oral"
]
},
{
"@type": "MedicalCondition",
"name": "Spinal Muscular Atrophy",
"alternateName": [
"SMA"
]
}
]
},
{
"@context": "https://schema.org",
"@type": "VideoObject",
"name": "Evrysdi gets here, there, EVERYWHERE",
"description": "Watch our ambassadors doing the things they love.",
"thumbnailUrl": "https://cf-images.us-east-1.prod.boltdns.net/v1/static/6125588073001/15ff087d-0e43-4566-82de-c98713ca555e/7318bf6a-37a4-4e6d-a970-805ae7e2c88f/1280x720/match/image.jpg",
"uploadDate": "2025-04-09T18:05:16.884Z",
"duration": "PT1M0.139S"
}
]
/about-evrysdi/how-evrysdi-works.html
[
{
"@context": "http://schema.org",
"@type": "Organization",
"name": "Genentech",
"url": "https://www.gene.com/",
"logo": "https://www.gene.com/assets/frontend/img/Genentech_logo.png",
"description": "Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.",
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+1-877-436-3683",
"contactType": "customer service"
},
"address": {
"@type": "PostalAddress",
"streetAddress": "1 DNA Way",
"addressLocality": "South San Francisco",
"addressRegion": "California",
"postalCode": "94080",
"addressCountry": "US"
}
},
{
"@context": "schema.org",
"@type": "MedicalWebPage",
"url": "https://www.evrysdi.com/about-evrysdi/how-evrysdi-works.html",
"description": "Learn about how Evrysdi® (risdiplam) works as a treatment for spinal muscular atrophy (SMA). Please read Important Safety Information, including the Full Prescribing Information for more details.",
"MedicalAudience": "https://schema.org/Patient",
"about": [
{
"@type": "Drug",
"name": "Evrysdi®",
"nonProprietaryName": "risdiplam",
"dosageForm": [
"Liquid",
"Tablet"
],
"administrationRoute": [
"Oral"
]
},
{
"@type": "MedicalCondition",
"name": "Spinal Muscular Atrophy",
"alternateName": [
"SMA"
]
}
]
}
]
/about-sma/why-treatment-matters-adults.html
[
{
"@context": "http://schema.org",
"@type": "Organization",
"name": "Genentech",
"url": "https://www.gene.com/",
"logo": "https://www.gene.com/assets/frontend/img/Genentech_logo.png",
"description": "Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.",
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+1-877-436-3683",
"contactType": "customer service"
},
"address": {
"@type": "PostalAddress",
"streetAddress": "1 DNA Way",
"addressLocality": "South San Francisco",
"addressRegion": "California",
"postalCode": "94080",
"addressCountry": "US"
}
},
{
"@context": "schema.org",
"@type": "MedicalWebPage",
"url": "https://www.evrysdi.com/about-sma/why-treatment-matters-adults.html",
"description": "Discover why SMA treatment is essential for adults, how it can slow disease progression, and how it may help improve or preserve motor function and strength. Please see Important Safety Information, including the Full Prescribing Information for more details.",
"MedicalAudience": "https://schema.org/Patient",
"about": [
{
"@type": "Drug",
"name": "Evrysdi®",
"nonProprietaryName": "risdiplam",
"dosageForm": [
"Liquid",
"Tablet"
],
"administrationRoute": [
"Oral"
]
},
{
"@type": "MedicalCondition",
"name": "Spinal Muscular Atrophy",
"alternateName": [
"SMA"
]
}
]
}
]
/resources/support-for-you.html
[
{
"@context": "http://schema.org",
"@type": "Organization",
"name": "Genentech",
"url": "https://www.gene.com/",
"logo": "https://www.gene.com/assets/frontend/img/Genentech_logo.png",
"description": "Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.",
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+1-877-436-3683",
"contactType": "customer service"
},
"address": {
"@type": "PostalAddress",
"streetAddress": "1 DNA Way",
"addressLocality": "South San Francisco",
"addressRegion": "California",
"postalCode": "94080",
"addressCountry": "US"
}
},
{
"@context": "schema.org",
"@type": "MedicalWebPage",
"url": "https://www.evrysdi.com/resources/support-for-you.html",
"description": "MySMA Support from Genentech answers your questions about Evrysdi® (risdiplam). Its Partnership and Access Liaisons (PALs) are local points of contact that provide the answers. Please see Important Safety information, including the Full Prescribing Information for more details.",
"MedicalAudience": "https://schema.org/Patient",
"about": [
{
"@type": "Drug",
"name": "Evrysdi®",
"nonProprietaryName": "risdiplam",
"dosageForm": [
"Liquid",
"Tablet"
],
"administrationRoute": [
"Oral"
]
},
{
"@type": "MedicalCondition",
"name": "Spinal Muscular Atrophy",
"alternateName": [
"SMA"
]
}
]
}
]
🛡️ Trust Signals — external proof links that back the declared identity
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 0 | 2 |
| /about-evrysdi/how-evrysdi-works.html | 0 | 2 |
| /about-sma/why-treatment-matters-adults.html | 0 | 2 |
| /resources/support-for-you.html | 0 | 2 |
This page presents a snapshot of public data from Genentech / Evrysdi, captured on May 30, 2026, to show how machine logic reads Identity & Authority signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to Genentech / Evrysdi: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://evrysdi.com to view the most current version of its content and see directly what this company is about and what it offers.